Your browser doesn't support javascript.
loading
Quaternary nanoparticles enable sustained release of bortezomib for hepatocellular carcinoma.
Li, Ling; Zhang, Yicheng; Zhou, Yang; Hu, Haijie; Hu, Yizong; Georgiades, Christos; Mao, Hai-Quan; Selaru, Florin M.
Afiliación
  • Li L; Division of Gastroenterology and HepatologySchool of MedicineJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Zhang Y; Institute for NanoBioTechnologyJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Zhou Y; Department of Materials Science and EngineeringWhiting School of EngineeringJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Hu H; Institute for NanoBioTechnologyJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Hu Y; Department of Materials Science and EngineeringWhiting School of EngineeringJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Georgiades C; Division of Gastroenterology and HepatologySchool of MedicineJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Mao HQ; Institute for NanoBioTechnologyJohns Hopkins UniversityBaltimoreMarylandUSA.
  • Selaru FM; Department of Biomedical EngineeringSchool of MedicineJohns Hopkins UniversityBaltimoreMarylandUSA.
Hepatology ; 76(6): 1660-1672, 2022 12.
Article en En | MEDLINE | ID: mdl-35596926
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Nanopartículas / Neoplasias Hepáticas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quimioembolización Terapéutica / Carcinoma Hepatocelular / Nanopartículas / Neoplasias Hepáticas / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Hepatology Año: 2022 Tipo del documento: Article